May 11, 2018 / 10:20 AM / 4 months ago

BRIEF-Novus Therapeutics Reports Quarterly Loss Per Share Of $0.36

May 11 (Reuters) - Novus Therapeutics Inc:

* QUARTERLY LOSS PER SHARE $0.36

* NOVUS THERAPEUTICS SAYS HAD $22.5 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31 - SEC FILING Source text: (bit.ly/2rza3AD) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below